Superior performance for accurate DOAC testing
Direct Oral Anticoagulants (DOACs), such as dabigatran and rivaroxaban, do not require routine monitoring.  However, there are instances when determining levels of these drugs may be warranted.  The HemosIL DOAC Assay Panel provides superior analytical performance in a standardized and validated automated solution.